Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Procter

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Human Mutation|March 26, 2003
Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short statureDavid S Millar, Mark D Lewis, Martin Horan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathwayMark D Lewis, Martin Horan, David S Millar, et al.
The Journal of Clinical Investigation|March 28, 2017
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humansFederica Buonocore, Peter Kühnen, Jenifer P Suntharalingham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialM Untch, R D Gelber, C Jackisch, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Human Mutation|March 26, 2003
Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short statureDavid S Millar, Mark D Lewis, Martin Horan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathwayMark D Lewis, Martin Horan, David S Millar, et al.
The Journal of Clinical Investigation|March 28, 2017
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humansFederica Buonocore, Peter Kühnen, Jenifer P Suntharalingham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trialM Untch, R D Gelber, C Jackisch, et al.
Pageof 5